Skip to main content
Top

23-10-2024 | Oral Cancer | Original Article

Diagnostic and Prognostic Accuracy of MMPs and TIMPs in Oral Cancer Patients on Enzyme-Linked Immunosorbent Assay (ELISA) as Compared to Immunohistochemistry (IHC)

Authors: Jyoti Saini, Jaimanti Bakshi, Naresh Kumar Panda, Maryada Sharma, Ashok Kumar Yadav, Suruthy Narayansami, Atul Kumar Goyal

Published in: Indian Journal of Surgical Oncology

Login to get access

Abstract

Oral cancer is one of most common noncommunicable diseases that imposed significant burden on healthcare around the globe including India. Several molecular markers have been extensively researched for their potential as diagnostic and prognostic biomarkers for oral cancer. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) found to play a crucial role in cytoskeleton dynamics and thus tumor growth and metastasis. The present study aims to analyze the MMP (MMP-1, MMP-3, MMP-9, and MMP-13) and TIMP (TIMP-1 and TIMP-3) expression in the oral cancer patients as compared to healthy controls. We also aim to compare the diagnostic accuracy of MMPs and TIMPs on enzyme-linked immunosorbent assay (ELISA) with respect to the immunohistochemistry (IHC). A total of 15 oral cancer patients and 14 healthy controls were enrolled in this study. Blood sample from oral cancer patients and healthy controls was obtained to analyze the MMP and TIMP expression levels in serum sample using ELISA. Tumor tissue sample from patients for IHC analysis was obtained by biopsy under local anesthesia. Data were compared between ELISA and IHC for sensitivity and specificity analysis. The mean age of the patients was 47.07 ± 15.74 years with the highest incidence of disease found in male gender (86.7%). MMPs and TIMPs exhibited higher expression in oral cancer patients as compared to healthy controls and the difference was statistically significant in case of MMP-13. MMPs and TIMPs showed stronger expression at advanced stages of cancer on IHC with MMP-9 exhibiting the highest expression level. The highest sensitivity and specificity on ELISA with respect to IHC were exhibited by the MMP-3 followed by MMP-13, TIMP-1, TIMP-3, and MMP-1. MMP-3 and MMP-13 were found to be reliable in terms of diagnostic marker for oral cancer as they found to have the highest sensitivity and specificity on ELISA with respect to IHC. MMP-9 was found to be reliable as a prognostic marker as it expresses highest on IHC at advanced stages of oral cancer.
Literature
2.
go back to reference Baburathinam S, Shyamsundar V, Aravindha BN, Karthika N, Vijaylakshmi R, Masthan KMK (2019) Expression of serum and salivary MMP-1 and MMP-9 in oral cancer, oral potentially malignant disorders and normal. J Biomed Pharm Res 8(3):123–131CrossRef Baburathinam S, Shyamsundar V, Aravindha BN, Karthika N, Vijaylakshmi R, Masthan KMK (2019) Expression of serum and salivary MMP-1 and MMP-9 in oral cancer, oral potentially malignant disorders and normal. J Biomed Pharm Res 8(3):123–131CrossRef
3.
go back to reference Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT et al (2006) Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction. Am Heart J 151(5):1101.e1-e8PubMedCrossRef Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT et al (2006) Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction. Am Heart J 151(5):1101.e1-e8PubMedCrossRef
4.
go back to reference Liutkevicius V, Lesauskaite V, Liutkeviciene R, Vaiciulis P, Uloza V (2020) Matrix metalloproteinases (MMP-2,-3,-9) gene polymorphisms in cases of benign vocal fold lesions and laryngeal carcinoma. In Vivo 34(1):267–274PubMedPubMedCentralCrossRef Liutkevicius V, Lesauskaite V, Liutkeviciene R, Vaiciulis P, Uloza V (2020) Matrix metalloproteinases (MMP-2,-3,-9) gene polymorphisms in cases of benign vocal fold lesions and laryngeal carcinoma. In Vivo 34(1):267–274PubMedPubMedCentralCrossRef
5.
go back to reference Patel BP, Shah SV, Shukla SN, Shah PM, Patel PS (2007) Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck 29(6):564–572PubMedCrossRef Patel BP, Shah SV, Shukla SN, Shah PM, Patel PS (2007) Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck 29(6):564–572PubMedCrossRef
6.
go back to reference Chen J-Q, Zhan W-H, He Y-L, Peng J-S, Wang J-P, Cai S-R et al (2004) Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas. World J Gastroenterol 10(6):776PubMedPubMedCentralCrossRef Chen J-Q, Zhan W-H, He Y-L, Peng J-S, Wang J-P, Cai S-R et al (2004) Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas. World J Gastroenterol 10(6):776PubMedPubMedCentralCrossRef
7.
8.
go back to reference Impola U, Uitto V-J, Hietanen J, Hakkinen L, Zhang L, Larjava H et al (2004) Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 202(1):14–22PubMedCrossRef Impola U, Uitto V-J, Hietanen J, Hakkinen L, Zhang L, Larjava H et al (2004) Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 202(1):14–22PubMedCrossRef
9.
go back to reference Johnson JL (2007) Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert Rev Cardiovasc Ther 5(2):265–282PubMedCrossRef Johnson JL (2007) Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert Rev Cardiovasc Ther 5(2):265–282PubMedCrossRef
10.
go back to reference Dollery CM, McEwan JR, Henney AM (1995) Matrix metalloproteinases and cardiovascular disease. Circ Res 77(5):863–868PubMedCrossRef Dollery CM, McEwan JR, Henney AM (1995) Matrix metalloproteinases and cardiovascular disease. Circ Res 77(5):863–868PubMedCrossRef
11.
go back to reference Lennarz WJ, Lane MD (2013) Encyclopedia of biological chemistry: Academic Press, Elsevier Inc Lennarz WJ, Lane MD (2013) Encyclopedia of biological chemistry: Academic Press, Elsevier Inc
12.
go back to reference Vu TH, Werb Z, Gelatinase B (1998) Structure, regulation, and function. In: Parks WC, Mecham RP (eds) Matrix metalloproteinases. Academic Press, San Diego, pp 115–148CrossRef Vu TH, Werb Z, Gelatinase B (1998) Structure, regulation, and function. In: Parks WC, Mecham RP (eds) Matrix metalloproteinases. Academic Press, San Diego, pp 115–148CrossRef
13.
go back to reference Brew K, Nagase H (2010) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochimica Biophysica Acta Mol Cell Res 1803(1):55–71CrossRef Brew K, Nagase H (2010) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochimica Biophysica Acta Mol Cell Res 1803(1):55–71CrossRef
14.
go back to reference Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, Ramirez-Acuña JM, Perez-Romero BA, Guerrero-Rodriguez JF et al (2020) The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci 21(24):9739PubMedPubMedCentralCrossRef Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, Ramirez-Acuña JM, Perez-Romero BA, Guerrero-Rodriguez JF et al (2020) The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci 21(24):9739PubMedPubMedCentralCrossRef
15.
go back to reference Mohan V, Talmi-Frank D, Arkadash V, Papo N, Sagi I (2016) Matrix metalloproteinase protein inhibitors: highlighting a new beginning for metalloproteinases in medicine. Metalloproteinases Med 3:31–47 Mohan V, Talmi-Frank D, Arkadash V, Papo N, Sagi I (2016) Matrix metalloproteinase protein inhibitors: highlighting a new beginning for metalloproteinases in medicine. Metalloproteinases Med 3:31–47
16.
go back to reference Saini J, Bakshi J, Panda NK, Sharma M, Yadav AK, Kamboj K et al (2024) Serum concentration of MMP-9 as a predictive biomarker for the progression of oral cancer. J Maxillofac Oral Surg 23:1079–1088 Saini J, Bakshi J, Panda NK, Sharma M, Yadav AK, Kamboj K et al (2024) Serum concentration of MMP-9 as a predictive biomarker for the progression of oral cancer. J Maxillofac Oral Surg 23:1079–1088
17.
go back to reference Patil R, Mahajan A, Pradeep G, Prakash N, Patil S, Khan SM (2021) Expression of matrix metalloproteinase-9 in histological grades of oral squamous cell carcinoma: an immunohistochemical study. J Oral Maxillofac Pathol 25(2):239–246PubMedPubMedCentralCrossRef Patil R, Mahajan A, Pradeep G, Prakash N, Patil S, Khan SM (2021) Expression of matrix metalloproteinase-9 in histological grades of oral squamous cell carcinoma: an immunohistochemical study. J Oral Maxillofac Pathol 25(2):239–246PubMedPubMedCentralCrossRef
18.
go back to reference Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, Gallo O (2002) Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck: correlation with p53 status, inducible nitric oxide synthase activity, and angiogenesis. Cancer 95(9):1902–1910PubMedCrossRef Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, Gallo O (2002) Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck: correlation with p53 status, inducible nitric oxide synthase activity, and angiogenesis. Cancer 95(9):1902–1910PubMedCrossRef
19.
go back to reference Omran OM, Shokry M, Ismail H, Omar G, Rezk M (2011) Expression of matrix metalloproteinases 2 and 9 in human trophoblasts of normal and preeclamptic placentas. Int J Health Sci 5(2 Suppl 1):21 Omran OM, Shokry M, Ismail H, Omar G, Rezk M (2011) Expression of matrix metalloproteinases 2 and 9 in human trophoblasts of normal and preeclamptic placentas. Int J Health Sci 5(2 Suppl 1):21
20.
go back to reference Bakshi J, Goyal AK, Saini J (2022) Quality of life in oral cancer patients following surgical excision and flap reconstruction. J Maxillofac Oral Surg 21(2):326–331PubMedCrossRef Bakshi J, Goyal AK, Saini J (2022) Quality of life in oral cancer patients following surgical excision and flap reconstruction. J Maxillofac Oral Surg 21(2):326–331PubMedCrossRef
21.
go back to reference Bakshi J, Goyal AK (2021) Clinical yoga trial aim to improve quality of life at advanced stages of oral cancer. Sport Sci Health 17(3):677–685CrossRef Bakshi J, Goyal AK (2021) Clinical yoga trial aim to improve quality of life at advanced stages of oral cancer. Sport Sci Health 17(3):677–685CrossRef
23.
go back to reference Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K et al (2024) Assessment of shame and stigma in head and neck cancer: a meta-analysis. J Maxillofac Oral Surg 23(1):16–22PubMedCrossRef Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K et al (2024) Assessment of shame and stigma in head and neck cancer: a meta-analysis. J Maxillofac Oral Surg 23(1):16–22PubMedCrossRef
24.
go back to reference Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K et al (2024) Shame and stigma over long-term survival in postoperative cases of head and neck cancer. J Maxillofac Oral Surg 23:1057–1062 Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K et al (2024) Shame and stigma over long-term survival in postoperative cases of head and neck cancer. J Maxillofac Oral Surg 23:1057–1062
25.
go back to reference Bakshi J, Tiwana H, Prashant S, Bahadur D, John J, Saini J et al (2022) Case report on surgical removal of 3.5 kg benign mesenchymal tumor from the mandible region. Egypt J Otolaryngol 38(1):134CrossRef Bakshi J, Tiwana H, Prashant S, Bahadur D, John J, Saini J et al (2022) Case report on surgical removal of 3.5 kg benign mesenchymal tumor from the mandible region. Egypt J Otolaryngol 38(1):134CrossRef
26.
go back to reference Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K et al (2022) Stigmatic impact of COVID-19 pandemic on head & neck cancers survivors. Indian J Otolaryngol Head Neck Surg 74(2):2912–2916PubMedCrossRef Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K et al (2022) Stigmatic impact of COVID-19 pandemic on head & neck cancers survivors. Indian J Otolaryngol Head Neck Surg 74(2):2912–2916PubMedCrossRef
27.
go back to reference Saini J, Bakshi J, Panda NK, Sharma M, Vir D, Goyal AK (2024) Cut-off points to classify numeric values of quality of life into normal, mild, moderate, and severe categories: an update for EORTC-QLQ-H&N35. Egypt J Otolaryngol 40(1):83CrossRef Saini J, Bakshi J, Panda NK, Sharma M, Vir D, Goyal AK (2024) Cut-off points to classify numeric values of quality of life into normal, mild, moderate, and severe categories: an update for EORTC-QLQ-H&N35. Egypt J Otolaryngol 40(1):83CrossRef
28.
go back to reference Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K et al (2023) Accuracy of a self-reported measure in psychological assessment when the instrument is self-administered by the patient or when administrated by the clinician. Indian J Otolaryngol Head Neck Surg 75(2):1266–1270PubMedCrossRef Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K et al (2023) Accuracy of a self-reported measure in psychological assessment when the instrument is self-administered by the patient or when administrated by the clinician. Indian J Otolaryngol Head Neck Surg 75(2):1266–1270PubMedCrossRef
30.
go back to reference Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K et al (2021) A hybrid method for the cross-cultural adaptation of self-report measures. Int J Appl Posit Psychol 6(1):45–54CrossRef Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K et al (2021) A hybrid method for the cross-cultural adaptation of self-report measures. Int J Appl Posit Psychol 6(1):45–54CrossRef
31.
go back to reference Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K et al (2022) Media commercials conveying awareness regarding prevention of head and neck cancer by focusing on stigmatized perspective of disease: right or wrong? Indian J Otolaryngol Head Neck Surg 74(3):5990–5993PubMedCrossRef Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K et al (2022) Media commercials conveying awareness regarding prevention of head and neck cancer by focusing on stigmatized perspective of disease: right or wrong? Indian J Otolaryngol Head Neck Surg 74(3):5990–5993PubMedCrossRef
32.
go back to reference Lotfi A, Mohammadi G, Tavassoli A, Chavoshi H, Saniee L (2015) Serum levels of MMP9 and MMP2 in patients with oral squamous cell carcinoma. Asian Pac J Cancer Prev 16(4):1327–1330PubMedCrossRef Lotfi A, Mohammadi G, Tavassoli A, Chavoshi H, Saniee L (2015) Serum levels of MMP9 and MMP2 in patients with oral squamous cell carcinoma. Asian Pac J Cancer Prev 16(4):1327–1330PubMedCrossRef
33.
go back to reference Peisker A, Raschke GF, Fahmy MD, Guentsch A, Roshanghias K, Hennings J et al (2017) Salivary MMP-9 in the detection of oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 22(3):e270PubMedPubMedCentral Peisker A, Raschke GF, Fahmy MD, Guentsch A, Roshanghias K, Hennings J et al (2017) Salivary MMP-9 in the detection of oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 22(3):e270PubMedPubMedCentral
34.
go back to reference Shpitzer T, Bahar G, Feinmesser R, Nagler RM (2007) A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol 133(9):613–617PubMedCrossRef Shpitzer T, Bahar G, Feinmesser R, Nagler RM (2007) A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol 133(9):613–617PubMedCrossRef
35.
go back to reference Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D, Borovoi I et al (2009) Salivary analysis of oral cancer biomarkers. Br J Cancer 101(7):1194–1198PubMedPubMedCentralCrossRef Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D, Borovoi I et al (2009) Salivary analysis of oral cancer biomarkers. Br J Cancer 101(7):1194–1198PubMedPubMedCentralCrossRef
36.
go back to reference Smriti K, Ray M, Chatterjee T, Shenoy R-P, Gadicherla S, Pentapati K-C et al (2020) Salivary MMP-9 as a biomarker for the diagnosis of oral potentially malignant disorders and oral squamous cell carcinoma. Asian Pac J Cancer Prev 21(1):233PubMedPubMedCentralCrossRef Smriti K, Ray M, Chatterjee T, Shenoy R-P, Gadicherla S, Pentapati K-C et al (2020) Salivary MMP-9 as a biomarker for the diagnosis of oral potentially malignant disorders and oral squamous cell carcinoma. Asian Pac J Cancer Prev 21(1):233PubMedPubMedCentralCrossRef
37.
go back to reference Dalirsani Z, Pakfetrat A, Delavarian Z, Hashemy SI, Mostaan LV, Abdollahnejad M et al (2019) Comparison of matrix metalloproteinases 2 and 9 levels in saliva and serum of patients with head and neck squamous cell carcinoma and healthy subjects. Int J Cancer Manag 12(5):e90249 Dalirsani Z, Pakfetrat A, Delavarian Z, Hashemy SI, Mostaan LV, Abdollahnejad M et al (2019) Comparison of matrix metalloproteinases 2 and 9 levels in saliva and serum of patients with head and neck squamous cell carcinoma and healthy subjects. Int J Cancer Manag 12(5):e90249
38.
go back to reference Pornchai O, Rhys-Evans PH, Eccles SA (2001) Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127(7):813–820 Pornchai O, Rhys-Evans PH, Eccles SA (2001) Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127(7):813–820
39.
go back to reference Kato K, Hara A, Kuno T, Kitaori N, Huilan Z, Mori H et al (2005) Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity. J Cancer Res Clin Oncol 131(6):340–346PubMedCrossRef Kato K, Hara A, Kuno T, Kitaori N, Huilan Z, Mori H et al (2005) Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity. J Cancer Res Clin Oncol 131(6):340–346PubMedCrossRef
40.
go back to reference Ikebe T, Shinohara M, Takeuchi H, Beppu M, Kurahara S-I, Nakamura S et al (1999) Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis 17(4):315–22PubMedCrossRef Ikebe T, Shinohara M, Takeuchi H, Beppu M, Kurahara S-I, Nakamura S et al (1999) Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis 17(4):315–22PubMedCrossRef
41.
go back to reference Champatyray S, Das SR, Bhuyan R, Debata P, Sahu MC (2019) Immunohistochemical expression of MMP9 in different grades of oral squamous cell carcinoma: our experience at tertiary care centre. Int J Pharm Sci Res 10(4):1880–1885 Champatyray S, Das SR, Bhuyan R, Debata P, Sahu MC (2019) Immunohistochemical expression of MMP9 in different grades of oral squamous cell carcinoma: our experience at tertiary care centre. Int J Pharm Sci Res 10(4):1880–1885
42.
go back to reference Singh RD, Haridas N, Patel JB, Shah FD, Shukla SN, Shah PM et al (2010) Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer. I J Clin Biochem 25(3):250–259CrossRef Singh RD, Haridas N, Patel JB, Shah FD, Shukla SN, Shah PM et al (2010) Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer. I J Clin Biochem 25(3):250–259CrossRef
43.
go back to reference Lee B-K, Kim M-J, Jang H-S, Lee H-R, Ahn K-M, Lee J-H et al (2008) A high concentration of MMP-2/gelatinase A and MMP-9/gelatinase B reduce NK cell-mediated cytotoxicity against an oral squamous cell carcinoma cell line. in vivo 22(5):593–7PubMed Lee B-K, Kim M-J, Jang H-S, Lee H-R, Ahn K-M, Lee J-H et al (2008) A high concentration of MMP-2/gelatinase A and MMP-9/gelatinase B reduce NK cell-mediated cytotoxicity against an oral squamous cell carcinoma cell line. in vivo 22(5):593–7PubMed
44.
go back to reference Riedel F, Götte K, Schwalb J, Hörmann K (2000) Serum levels of matrix metalloproteinase-2 and-9 in patients with head and neck squamous cell carcinoma. Anticancer Res 20(5A):3045–3049PubMed Riedel F, Götte K, Schwalb J, Hörmann K (2000) Serum levels of matrix metalloproteinase-2 and-9 in patients with head and neck squamous cell carcinoma. Anticancer Res 20(5A):3045–3049PubMed
45.
go back to reference Jahanshahi G, Talebi A, Derisavy S (2018) The sensitivity and specificity of saliva biomarker MMP-9 for detection oral squamous cell carcinoma (OSCC). ARC J Cancer Sci 4(2):25–30 Jahanshahi G, Talebi A, Derisavy S (2018) The sensitivity and specificity of saliva biomarker MMP-9 for detection oral squamous cell carcinoma (OSCC). ARC J Cancer Sci 4(2):25–30
46.
go back to reference Phulari RG, Vasavada D, Shah A, Rathod R, Patel A, Patel S (2019) Immunoexpression of MMP-9 in metastasis of oral squamous cell carcinoma. Oral Maxillofac Pathol J 10(2):68–71 Phulari RG, Vasavada D, Shah A, Rathod R, Patel A, Patel S (2019) Immunoexpression of MMP-9 in metastasis of oral squamous cell carcinoma. Oral Maxillofac Pathol J 10(2):68–71
47.
go back to reference Chandolia B, Basu SK, Kumar M (2016) Can MMP-9 be a prognosticator marker for oral squamous cell carcinoma? J Clin Diagnos Res 10(1):ZC09 Chandolia B, Basu SK, Kumar M (2016) Can MMP-9 be a prognosticator marker for oral squamous cell carcinoma? J Clin Diagnos Res 10(1):ZC09
48.
go back to reference Benitha G, Ramani P, Jayaraman S, Abilasha R, Ramalingam K, Krishnan M (2023) Evaluation of serum levels of matrix metalloproteinase-9 (MMP-9) in oral squamous cell carcinoma and its clinicopathological correlation. Cureus 15(2):e34954 Benitha G, Ramani P, Jayaraman S, Abilasha R, Ramalingam K, Krishnan M (2023) Evaluation of serum levels of matrix metalloproteinase-9 (MMP-9) in oral squamous cell carcinoma and its clinicopathological correlation. Cureus 15(2):e34954
49.
go back to reference Bakshi J, Goyal AK, Singh V, Sannigrahi M, Khullar M (2020) Stage-specific expression analysis ofMMP-2 & MMP-9 in laryngeal carcinoma. J Cancer Res Ther 16(3):517–520PubMedCrossRef Bakshi J, Goyal AK, Singh V, Sannigrahi M, Khullar M (2020) Stage-specific expression analysis ofMMP-2 & MMP-9 in laryngeal carcinoma. J Cancer Res Ther 16(3):517–520PubMedCrossRef
50.
go back to reference Monea M, Pop AM (2022) The use of salivary levels of matrix metalloproteinases as an adjuvant method in the early diagnosis of oral squamous cell carcinoma: a narrative literature review. Curr Issues Mol Biol 44(12):6306–6322PubMedPubMedCentralCrossRef Monea M, Pop AM (2022) The use of salivary levels of matrix metalloproteinases as an adjuvant method in the early diagnosis of oral squamous cell carcinoma: a narrative literature review. Curr Issues Mol Biol 44(12):6306–6322PubMedPubMedCentralCrossRef
51.
go back to reference Stott-Miller M, Houck JR, Lohavanichbutr P, Méndez E, Upton MP, Futran ND et al (2011) Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma. Cancer Epidemiol Biomark Prev 20(12):2628–2636CrossRef Stott-Miller M, Houck JR, Lohavanichbutr P, Méndez E, Upton MP, Futran ND et al (2011) Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma. Cancer Epidemiol Biomark Prev 20(12):2628–2636CrossRef
53.
go back to reference Cai M, Zheng Z, Bai Z, Ouyang K, Wu Q, Xu S et al (2022) Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers. BMC Cancer 22(1):1–15CrossRef Cai M, Zheng Z, Bai Z, Ouyang K, Wu Q, Xu S et al (2022) Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers. BMC Cancer 22(1):1–15CrossRef
54.
go back to reference Wróbel-Roztropiński A, Zielińska-Kaźmierska B, Roztropiński H, Lucas-Grzelczyk W, Szemraj J, Józefowicz-Korczyńska M (2021) Expression of matrix metalloproteinases (MMPs) and their inhibitor (TIMP) genes on mRNA and protein levels in oral squamous cell carcinoma. Biul Pol Towarz Onkologicznego Nowotwory 6(1):1–8 Wróbel-Roztropiński A, Zielińska-Kaźmierska B, Roztropiński H, Lucas-Grzelczyk W, Szemraj J, Józefowicz-Korczyńska M (2021) Expression of matrix metalloproteinases (MMPs) and their inhibitor (TIMP) genes on mRNA and protein levels in oral squamous cell carcinoma. Biul Pol Towarz Onkologicznego Nowotwory 6(1):1–8
55.
go back to reference Nosratzehi T, Alijani E, Moodi M (2017) Salivary MMP-1, MMP-2, MMP-3 and MMP-13 levels in patients with oral lichen planus and squamous cell carcinoma. Asian Pac J Cancer Prev 18(7):1947PubMedPubMedCentral Nosratzehi T, Alijani E, Moodi M (2017) Salivary MMP-1, MMP-2, MMP-3 and MMP-13 levels in patients with oral lichen planus and squamous cell carcinoma. Asian Pac J Cancer Prev 18(7):1947PubMedPubMedCentral
56.
go back to reference Yu J-S, Chen Y-T, Chiang W-F, Hsiao Y-C, Chu LJ, See L-C et al (2016) Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan. Proceed Nat Acad Sci 113(41):11549–11554CrossRef Yu J-S, Chen Y-T, Chiang W-F, Hsiao Y-C, Chu LJ, See L-C et al (2016) Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan. Proceed Nat Acad Sci 113(41):11549–11554CrossRef
57.
go back to reference Choudhry N, Sarmad S, Gondal AJ (2019) Estimation of serum matrix metalloproteinases among patients of oral squamous cell carcinoma. Pak J Med Sci 35(1):252PubMedPubMedCentralCrossRef Choudhry N, Sarmad S, Gondal AJ (2019) Estimation of serum matrix metalloproteinases among patients of oral squamous cell carcinoma. Pak J Med Sci 35(1):252PubMedPubMedCentralCrossRef
58.
go back to reference Chang Y-T, Chu LJ, Liu Y-C, Chen C-J, Wu S-F, Chen C-H et al (2020) Verification of saliva matrix metalloproteinase-1 as a strong diagnostic marker of oral cavity cancer. Cancer 12(8):2273CrossRef Chang Y-T, Chu LJ, Liu Y-C, Chen C-J, Wu S-F, Chen C-H et al (2020) Verification of saliva matrix metalloproteinase-1 as a strong diagnostic marker of oral cavity cancer. Cancer 12(8):2273CrossRef
59.
go back to reference Chu LJ, Chang Y-T, Chien C-Y, Chung H-C, Wu S-F, Chen C-J et al (2024) Clinical validation of a saliva-based matrix metalloproteinase-1 rapid strip test for detection of oral cavity cancer. Biomed J 47(1):100594PubMedCrossRef Chu LJ, Chang Y-T, Chien C-Y, Chung H-C, Wu S-F, Chen C-J et al (2024) Clinical validation of a saliva-based matrix metalloproteinase-1 rapid strip test for detection of oral cavity cancer. Biomed J 47(1):100594PubMedCrossRef
60.
go back to reference Lin CW, Tseng SW, Yang SF, Ko CP, Lin CH, Wei LH et al (2012) Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer. Oral Dis 18(8):734–740PubMedCrossRef Lin CW, Tseng SW, Yang SF, Ko CP, Lin CH, Wei LH et al (2012) Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer. Oral Dis 18(8):734–740PubMedCrossRef
61.
go back to reference Atla B, Prabhakula S, Kumar SS, Boni LS (2018) Matrix metalloproteinase-9 (MMP-9) as prospective histopathological and molecular biomarker for oral squamous cell carcinoma. Int J Res Med Sci 6(8):2801–2807CrossRef Atla B, Prabhakula S, Kumar SS, Boni LS (2018) Matrix metalloproteinase-9 (MMP-9) as prospective histopathological and molecular biomarker for oral squamous cell carcinoma. Int J Res Med Sci 6(8):2801–2807CrossRef
62.
go back to reference Katayama A, Bandoh N, Kishibe K, Takahara M, Ogino T, Nonaka S et al (2004) Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis. Clin Cancer Res 10(2):634–640PubMedCrossRef Katayama A, Bandoh N, Kishibe K, Takahara M, Ogino T, Nonaka S et al (2004) Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis. Clin Cancer Res 10(2):634–640PubMedCrossRef
63.
go back to reference Kurahara SI, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A et al (1999) Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 21(7):627–38PubMedCrossRef Kurahara SI, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A et al (1999) Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 21(7):627–38PubMedCrossRef
64.
go back to reference Zhou C, Gao Y, Johnson N, Gao J (2010) Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue. Aust Dent J 55(4):385–389PubMedCrossRef Zhou C, Gao Y, Johnson N, Gao J (2010) Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue. Aust Dent J 55(4):385–389PubMedCrossRef
65.
go back to reference Fan H-X, Li H-X, Chen D, Gao Z-X, Zheng J-H (2012) Changes in the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implications. J Exp Clin Cancer Res 31(1):1–8CrossRef Fan H-X, Li H-X, Chen D, Gao Z-X, Zheng J-H (2012) Changes in the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implications. J Exp Clin Cancer Res 31(1):1–8CrossRef
66.
go back to reference Shahsavari M, Mazreah SA, Shoghi A, Gheysari R (2022) Evaluation of matrix metalloproteinases 2 and 9 in oral squamous cell carcinoma and verrucous carcinoma. Int J High Risk Behav Addict 11(2):e109491 Shahsavari M, Mazreah SA, Shoghi A, Gheysari R (2022) Evaluation of matrix metalloproteinases 2 and 9 in oral squamous cell carcinoma and verrucous carcinoma. Int J High Risk Behav Addict 11(2):e109491
67.
go back to reference Dai T, Song Y, Ma H, Feng H (2007) Studies on the expression of MMP-9 and significance of a macrophage assay in oral squamous cell carcinoma. Chinese J Clin Oncol 4:333–337CrossRef Dai T, Song Y, Ma H, Feng H (2007) Studies on the expression of MMP-9 and significance of a macrophage assay in oral squamous cell carcinoma. Chinese J Clin Oncol 4:333–337CrossRef
68.
go back to reference Ravi DK, Kumar M, Singh G, Rai SB, Chincholkar T, Saxena AK et al (2014) Matrix metallopeptidase 9 (MMP-9) expression in oral cancer andand adjacent normal tissue. World J Surg Med Radiation Oncol 3(17):96–101 Ravi DK, Kumar M, Singh G, Rai SB, Chincholkar T, Saxena AK et al (2014) Matrix metallopeptidase 9 (MMP-9) expression in oral cancer andand adjacent normal tissue. World J Surg Med Radiation Oncol 3(17):96–101
69.
go back to reference Zaidi SJ, Riaz N, Iqbal A, Khan AA (2021) Salivary matrix metalloproteinase (MMP)-1 as non-invasive tool for the diagnosis of oral squamous cell carcinoma (OSCC). J Pak Dent Assoc 30(1):18–23 Zaidi SJ, Riaz N, Iqbal A, Khan AA (2021) Salivary matrix metalloproteinase (MMP)-1 as non-invasive tool for the diagnosis of oral squamous cell carcinoma (OSCC). J Pak Dent Assoc 30(1):18–23
70.
go back to reference Zhong Z-T, Ashraf G, Chen W, Liu B, Wang G-P, Zhao Y-D (2022) Detection of matrix metalloproteinase-1 in human saliva based on a pregnancy test strip platform. Anal Chem 94(47):16384–16392PubMedCrossRef Zhong Z-T, Ashraf G, Chen W, Liu B, Wang G-P, Zhao Y-D (2022) Detection of matrix metalloproteinase-1 in human saliva based on a pregnancy test strip platform. Anal Chem 94(47):16384–16392PubMedCrossRef
Metadata
Title
Diagnostic and Prognostic Accuracy of MMPs and TIMPs in Oral Cancer Patients on Enzyme-Linked Immunosorbent Assay (ELISA) as Compared to Immunohistochemistry (IHC)
Authors
Jyoti Saini
Jaimanti Bakshi
Naresh Kumar Panda
Maryada Sharma
Ashok Kumar Yadav
Suruthy Narayansami
Atul Kumar Goyal
Publication date
23-10-2024
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-024-02113-7
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

  • Webinar | 06-02-2024 | 20:00 (CET)

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now